drugset / Trial / NCT00913198
A Study of CP-4126 in Patients With Advanced Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
The main objective of this study is to assess the biological activity of CP-4126 in patients with advanced pancreatic cancer. In addition, the correlation between hENT1 (human equilibrative nucleoside transporter 1) and overall survival will be studied.
Timeline
- Start
- 2009-04
- Primary completion
- 2011-06
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | gemcitabine elaidate | Small molecule | 1250 mg/m2 | Intravenous |